The European Research Initiative on CLL (ERIC) 2020 Virtual Meeting, New Frontiers in CLL Research, was held on 1-3 October 2020. Leading experts in the field discussed the latest in CLL research, from basic to translational and clinical.

Highlights from this year’s ERIC International Meeting include gene and microenvironment cross-talk, rational use of biomarkers, patient stratification, novel therapeutic targets and appropriate patient management.

View all videos

ERIC 2020

European Research Initiative on CLL (ERIC) 2020 Virtual Meeting
1-3 October 2020

Promising findings from the Phase II MAGNOLIA trial of next-gen TKI #Zanubrutinib for R/R marginal zone #Lymphoma

Hear more from @OpatStephen of @MonashUni: http://ow.ly/OyWN50EiVPi

#ASH2020 @ASH_hematology #HemOnc #NonHodgkinLymphoma #Lymsm #CTSM #TrialUpdate

Hugely #inspiring #AACR21 plenary session on #cancer #chromosomal instability and linkage to #immune responses and therapeutic vulnerabilities @AACR David Pellman @Samuel_Bakhoum Stephen Jackson @KarleneCimprich @CharlesSwanton @ZStorchova #CelebrateScience

We can't wait for the next #VJSessions all about the EBMT Trainee Committee!

We are delighted to be joined by @NicoGagelmann @Claire_P_Horgan & @YasSerroukh on 14 April at 1pm EST/7pm CEST

Register here: http://ow.ly/RbO450Ebhc9

@TheEBMT_Trainee @TheEBMT #EBMT21 #OncoAlert

At #AACR21 we spoke w/ Tracy George (@UUtah) on areas of unmet needs for patients with #Mastocytosis

Watch here 👉http://ow.ly/PdoJ50ElliT

@VHemonc @AACR #RareDisease #Mastocytosis #MCAS #MastCellDisease #OncoAlert

Load More...

ERIC 2020

European Research Initiative on CLL (ERIC) 2020 Virtual Meeting
1-3 October 2020

The European Research Initiative on CLL (ERIC) 2020 Virtual Meeting, New Frontiers in CLL Research, was held on 1-3 October 2020. Leading experts in the field discussed the latest in CLL research, from basic to translational and clinical.

Highlights from this year’s ERIC International Meeting include gene and microenvironment cross-talk, rational use of biomarkers, patient stratification, novel therapeutic targets and appropriate patient management.

View all videos

Promising findings from the Phase II MAGNOLIA trial of next-gen TKI #Zanubrutinib for R/R marginal zone #Lymphoma

Hear more from @OpatStephen of @MonashUni: http://ow.ly/OyWN50EiVPi

#ASH2020 @ASH_hematology #HemOnc #NonHodgkinLymphoma #Lymsm #CTSM #TrialUpdate

Hugely #inspiring #AACR21 plenary session on #cancer #chromosomal instability and linkage to #immune responses and therapeutic vulnerabilities @AACR David Pellman @Samuel_Bakhoum Stephen Jackson @KarleneCimprich @CharlesSwanton @ZStorchova #CelebrateScience

We can't wait for the next #VJSessions all about the EBMT Trainee Committee!

We are delighted to be joined by @NicoGagelmann @Claire_P_Horgan & @YasSerroukh on 14 April at 1pm EST/7pm CEST

Register here: http://ow.ly/RbO450Ebhc9

@TheEBMT_Trainee @TheEBMT #EBMT21 #OncoAlert

At #AACR21 we spoke w/ Tracy George (@UUtah) on areas of unmet needs for patients with #Mastocytosis

Watch here 👉http://ow.ly/PdoJ50ElliT

@VHemonc @AACR #RareDisease #Mastocytosis #MCAS #MastCellDisease #OncoAlert

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter